Targeted Immunization Strategies and Designing Vaccine against Indian Nipah Virus Strain (NiV B) and Malaysian Variant (NiV M)
Open Access
- 27 September 2024
- journal article
- research article
- Published by Manuscript Technomedia LLP in International Journal of Pharmaceutical Investigation
- Vol. 14 (4) , 1201-1207
Abstract
Background Nipah virus is a deadly infectious virus that was first isolated and identified from Malaysia. Since then, a number of Nipah virus outbreaks have been reported from Bangladesh and India. Transmission of the disease occurs through Pteropus genus fruit bats. The case fatality rate of this infection is very high when compared with other viral zoonoses. At present, there are no approved vaccines or drugs available to prevent or treat this infection. A number of studies are ongoing to develop an efficient vaccine candidate to combat this deadly virus. The majority of them concentrate on the structural and non-structural proteins, which are the main targets of neutralizing antibodies. Materials and Methods Here, we analyzed the genome sequence identity of two Nipah virus strains, Indian and Malaysian, and also the amino acid identity between the two structural proteins (Attachment glycoprotein G and Fusion protein F) and one non-structural protein (W protein) of those two strains. Results and Discussion It was found that there is a considerable amount of nucleotide sequence homology between the initial strain that originated from Malaysia and the strain that is now found in India. Furthermore, the Structural and Non-structural proteins of these two strains exhibit a high degree of similarity. Conclusion Hence, a vaccine candidate designed using either NiV M or NiV B can be effectively used as a potent vaccine.Keywords
This publication has 28 references indexed in Scilit:
- Both chimpanzee adenovirus-vectored and DNA vaccines induced long-term immunity against Nipah virus infectionnpj Vaccines, 2023
- Novel “GaEl Antigenic Patches” Identified by a “Reverse Epitomics” Approach to Design Multipatch Vaccines against NIPAH Infection, a Silent Threat to Global Human HealthACS Omega, 2023
- Genomic characterization, transcriptome analysis, and pathogenicity of the Nipah virus (Indian isolate)Virulence, 2023
- Molecular Pathogenesis of Nipah VirusApplied Biochemistry and Biotechnology, 2023
- Stability analysis and system properties of Nipah virus transmission: A fractional calculus case studyChaos, Solitons & Fractals, 2022
- Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate modelEBioMedicine, 2022
- Medical countermeasures against henipaviruses: a review and public health perspectiveThe Lancet Infectious Diseases, 2021
- Anticipation of Antigenic Sites for the Goal of Vaccine Designing Against Nipah Virus: An Immunoinformatics Inquisitive QuestInternational Journal of Peptide Research and Therapeutics, 2021
- A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virusnpj Vaccines, 2021
- Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies – a comprehensive reviewVeterinary Quarterly, 2019